These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31981599)

  • 1. Baseline high levels of complement component 4 predict worse clinical outcome at 1-year follow-up in first-episode psychosis.
    Mondelli V; Di Forti M; Morgan BP; Murray RM; Pariante CM; Dazzan P
    Brain Behav Immun; 2020 Aug; 88():913-915. PubMed ID: 31981599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of peripheral complement factors across stages of psychosis.
    Laskaris L; Zalesky A; Weickert CS; Di Biase MA; Chana G; Baune BT; Bousman C; Nelson B; McGorry P; Everall I; Pantelis C; Cropley V
    Schizophr Res; 2019 Feb; 204():30-37. PubMed ID: 30527272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis.
    Mondelli V; Ciufolini S; Belvederi Murri M; Bonaccorso S; Di Forti M; Giordano A; Marques TR; Zunszain PA; Morgan C; Murray RM; Pariante CM; Dazzan P
    Schizophr Bull; 2015 Sep; 41(5):1162-70. PubMed ID: 25829375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.
    Crespo-Facorro B; Pelayo-Terán JM; Pérez-Iglesias R; Ramírez-Bonilla M; Martínez-García O; Pardo-García G; Vázquez-Barquero JL
    J Psychiatr Res; 2007 Oct; 41(8):659-66. PubMed ID: 16797591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study.
    Kravariti E; Demjaha A; Zanelli J; Ibrahim F; Wise C; MacCabe JH; Reichenberg A; Pilecka I; Morgan K; Fearon P; Morgan C; Doody GA; Donoghue K; Jones PB; Kaçar AŞ; Dazzan P; Lappin J; Murray RM
    Psychol Med; 2019 Sep; 49(12):2100-2110. PubMed ID: 30348234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between Genotype and Peripheral Complement Proteins in First-Episode Psychosis: Evidences From C3 and C4.
    Chen Y; Zhao Z; Lin F; Wang L; Lin Z; Yue W
    Front Genet; 2021; 12():647246. PubMed ID: 34306006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical folding defects as markers of poor treatment response in first-episode psychosis.
    Palaniyappan L; Marques TR; Taylor H; Handley R; Mondelli V; Bonaccorso S; Giordano A; McQueen G; DiForti M; Simmons A; David AS; Pariante CM; Murray RM; Dazzan P
    JAMA Psychiatry; 2013 Oct; 70(10):1031-40. PubMed ID: 23945954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble terminal complement complex blood levels are elevated in schizophrenia.
    Savukoski S; Mannes M; Wohlgemuth L; Schultze A; Guest PC; Meyer-Lotz G; Dobrowolny H; Relja B; Huber-Lang M; Steiner J
    Eur Arch Psychiatry Clin Neurosci; 2024 Aug; 274(5):1215-1222. PubMed ID: 38243017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical Trial.
    Susai SR; Föcking M; Mongan D; Heurich M; Coutts F; Egerton A; Whetton T; Winter-van Rossum I; Unwin RD; Pollak TA; Weiser M; Leboyer M; Rujescu D; Byrne JF; Gifford GW; Dazzan P; Koutsouleris N; Kahn RS; Cotter DR; McGuire P
    Schizophr Bull; 2023 Jul; 49(4):893-902. PubMed ID: 36916850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying neurocognitive markers for outcome prediction of global functioning in individuals with first-episode and ultra-high-risk for psychosis.
    Sawada K; Kanehara A; Sakakibara E; Eguchi S; Tada M; Satomura Y; Suga M; Koike S; Kasai K
    Psychiatry Clin Neurosci; 2017 May; 71(5):318-327. PubMed ID: 28294477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis.
    Zhang JP; Robinson D; Yu J; Gallego J; Fleischhacker WW; Kahn RS; Crespo-Facorro B; Vazquez-Bourgon J; Kane JM; Malhotra AK; Lencz T
    Am J Psychiatry; 2019 Jan; 176(1):21-28. PubMed ID: 30392411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory and cardiometabolic markers at presentation with first episode psychosis and long-term clinical outcomes: A longitudinal study using electronic health records.
    Osimo EF; Perry BI; Cardinal RN; Lynall ME; Lewis J; Kudchadkar A; Murray GK; Perez J; Jones PB; Khandaker GM
    Brain Behav Immun; 2021 Jan; 91():117-127. PubMed ID: 32950620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement system biomarkers in first episode psychosis.
    Kopczynska M; Zelek W; Touchard S; Gaughran F; Di Forti M; Mondelli V; Murray R; O'Donovan MC; Morgan BP
    Schizophr Res; 2019 Feb; 204():16-22. PubMed ID: 29279246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline psychopathology and relationship to longitudinal functional outcome in attenuated and early first episode psychosis.
    Burton CZ; Tso IF; Carrión RE; Niendam T; Adelsheim S; Auther AM; Cornblatt BA; Carter CS; Melton R; Sale TG; Taylor SF; McFarlane WR
    Schizophr Res; 2019 Oct; 212():157-162. PubMed ID: 31395490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter integrity as a predictor of response to treatment in first episode psychosis.
    Reis Marques T; Taylor H; Chaddock C; Dell'acqua F; Handley R; Reinders AA; Mondelli V; Bonaccorso S; Diforti M; Simmons A; David AS; Murray RM; Pariante CM; Kapur S; Dazzan P
    Brain; 2014 Jan; 137(Pt 1):172-82. PubMed ID: 24253201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission.
    Henry LP; Amminger GP; Harris MG; Yuen HP; Harrigan SM; Prosser AL; Schwartz OS; Farrelly SE; Herrman H; Jackson HJ; McGorry PD
    J Clin Psychiatry; 2010 Jun; 71(6):716-28. PubMed ID: 20573330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower complement C1q levels in first-episode psychosis and in schizophrenia.
    Koskuvi M; Malwade S; Gracias Lekander J; Hörbeck E; Bruno S; Holmen Larsson J; Pelanis A; Isgren A; Goulding A; Fatouros-Bergman H; Samudyata ; Schalling M; Piehl F; Erhardt S; Landen M; Cervenka S; Orhan F; Sellgren CM
    Brain Behav Immun; 2024 Mar; 117():313-319. PubMed ID: 38301948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of functional and clinical outcome in early-onset first-episode psychosis: the child and adolescent first episode of psychosis (CAFEPS) study.
    Parellada M; Castro-Fornieles J; Gonzalez-Pinto A; Pina-Camacho L; Moreno D; Rapado-Castro M; Otero S; de la Serna E; Moreno C; Baeza I; Graell M; Arango C
    J Clin Psychiatry; 2015 Nov; 76(11):e1441-8. PubMed ID: 26580481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.